Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies.

Castellanos-Rueda, Rocío; Di Roberto, Raphaël B; Schlatter, Fabrice S; Reddy, Sai T

Castellanos-Rueda, Rocío; Di Roberto, Raphaël B; Schlatter, Fabrice S; Reddy, Sai T.

Afiliación

Castellanos-Rueda R; ETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Di Roberto RB; ETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Schlatter FS; ETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Reddy ST; ETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland. Electronic address: sai.reddy@ethz.ch.

Trends Biotechnol ; 39(12): 1308-1320, 2021 12.

Article en En | MEDLINE | ID: mdl-33832782

Asunto(s)

Neoplasias; RNA-Seq; Receptores Quiméricos de Antígenos; Análisis de la Célula Individual; Humanos; Inmunoterapia Adoptiva; Monitoreo Fisiológico/métodos; Neoplasias/genética; Neoplasias/terapia; RNA-Seq/métodos; Receptores Quiméricos de Antígenos/genética; Receptores Quiméricos de Antígenos/metabolismo; Linfocitos T; Transcriptoma

Palabras clave

chimeric antigen receptor; immune profiling; single-cell RNA sequencing; transcriptomics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Análisis de la Célula Individual / Receptores Quiméricos de Antígenos / RNA-Seq / Neoplasias Límite: Humans Idioma: En Revista: Trends Biotechnol Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google